The Commonwealth is consulting on research and development tax incentive for clinical trials

Complex stuff demonstrated by consultation documents. Just how complex, the Group of Eight (in favour of “stronger incentives for researchers and partners”),  makes clear. “The support environment for commercialisation in Australia can be difficult to navigate and understand, and that the research and development tax incentive itself is perceived as a complex initiative, making any simplification for both user and decision-maker highly welcome.”

Much like IP proposals for the research commercialisation plan (CMM February 3, 14)